Dr. Sandra Milligan, President of Aspira, aims to accelerate OVAinform and ENDOinform development to commercialization in less than two years, utilizing ARPA-H funding.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Dr. Sandra Milligan, President of Aspira, aims to accelerate OVAinform and ENDOinform development to commercialization in less than two years, utilizing ARPA-H funding.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.